Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IBEX Technologies Inc V.IBT

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


TSXV:IBT - Post by User

Post by guarantor1on Apr 07, 2021 2:42pm
129 Views
Post# 32950696

Paul Baehr (IBT CEO) Comments regarding Diamine Oxidaseumber

Paul Baehr (IBT CEO) Comments regarding Diamine Oxidaseumberhttps://www.youtube.com/watch?v=CnEck4TM_Ec&t=11s

12:00
expected to bring to Market , in the next 2 - 3 years.,
It was moved into development about a year ago.

22:00
Its a small Niche
Those that have  Histamine Intolerance,
Have problems with wine, cheese and tomatoes,
They have an Inability to Produce DOA Endogenonsly,
And some people have comnpared this to Lactose Intolerance
And I don't beleive it,
The Market  is $10M
The Huge Advantage = The product we have is botanical
Hisdane  is extracted from Pig Kidney
And we think there is a very entry into this Market.
And the size of that Market=
The Low Hanging Fruit = 1/3 of the Market
And Very Quickly
And We expect 3 -5 M Sales out there
And then, this is not an Absolute Number
<< Previous
Bullboard Posts
Next >>